AMPLIA THERAPEUTICS ORDINARY (ATX) Short Interest
AMPLIA THERAPEUTICS ORDINARY (ASX:ATX) had 0.01% of shares reported as short positions as of 16 July 2026, representing 74,636 shares. AMPLIA THERAPEUTICS ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Amplia Therapeutics
Amplia Therapeutics Limited focuses on developing therapies targeting focal adhesion kinase (FAK) inhibitors for the treatment of cancer and fibrosis. The company is positioned within the biotechnology sector, leveraging advanced scientific research to develop clinical candidates aimed at unmet medical needs, potentially offering transformative therapies in oncology and fibrotic diseases.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4ATX intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Amplia Therapeutics
About
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss ATX
Start a research thread or post the first pulse update